← FDA DRUG APPROVALS

FDA ANDA · ANDA076411

METHENAMINE HIPPURATE

Sponsor: IMPAX LABS INC

APPLICATION
ANDA076411
TYPE
ANDA
ORIGINAL APPROVAL
2003-06-20
LATEST ACTION
2009-09-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METHENAMINE HIPPURATEDiscontinued
METHENAMINE HIPPURATE 1GM · TABLET · ORAL

Approval history

2009-09-15Labeling · Supplement 6AP
2006-03-08Labeling · Supplement 2AP
2005-01-21Labeling · Supplement 1AP
2003-06-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →